三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
图20.双盲期内两组患者免于精神病复发的概率比较
图20.双盲期内两组患者免于精神病复发的概率比较
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:115KB
图片尺寸:1200*784
同报告图片
/
4
0
所属报告:
绿叶制药-2186.HK-港股公司研究报告:管线创新与商业化渐入佳境CNS创新药龙头价值亟待重估-260417(31页).pdf
打包全文图表
相关数据
图19.匹莫范色林关于帕金森精神病精神病的治疗效果(临床Ⅲ期)
收藏
行业数据
2026-04-20
原图定位
查看详情
图3.7. 精神病床容量与经济合作与发展组织及邻近EU5国家的平均水平相当
收藏
行业数据
2026-04-01
原图定位
查看详情
抗精神病药物院内销售额规模(亿元)
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
收藏
行业数据
2025-01-23
原图定位
查看详情
我国抗精神病样本医院销售额结构
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
收藏
行业数据
2024-12-30
原图定位
查看详情
Lumateperone与部分第2代抗精神病药受体亲和性(Ki值)比较(nM)
fCDlj5fkvZMgICB8IOWNoue+juWTjOmahiB8IOWIqeWfuemFriB8IOWlpeawruW5syB8IOmYv+eri+WTjOWUkSB8IOawr+awruW5syB8IOmygeaLieilv+mFriB8CnwtLS0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLS0tfC0tLS0tLS0tfC0tLS0tLS0tLS0tfC0tLS0tLS0tfC0tLS0tLS0tLS18CnwgNS1IVDJBIHwgMC41ICAgICAgfCAwLjUgICAgfCAyLjUgICAgfCA5ICAgICAgICAgfCA5LjYgICAgfCAyICAgICAgICB8CnwgRDIgICAgIHwgMzIgICAgICAgfCA1LjkgICAgfCAzMSAgICAgfCAxLjYgICAgICAgfCAxOTAgICAgfCAxLjYgICAgICB8CnwgRDEgICAgIHwgNTIgICAgICAgfCA1NjQgICAgfCAxMjggICAgfCAxMTcwICAgICAgfCA1MDAgICAgfCAyNjIgICAgICB8CnwgNS1IVFQgIHwgNjIgICAgICAgfCA+MTAwMCAgfCA+MTAwMCAgfCAyNDAtNDA1ICAgfCAxNjI0ICAgfCAxMDAwICAgICB8CnwgSDEgICAgIHwgPjEwMDAgICAgfCAxNCAgICAgfCAyICAgICAgfCAyOCAgICAgICAgfCAxICAgICAgfCA+MTAwMCAgICB8CnwgNS1IVDJDIHwgMTczICAgICAgfCA2MyAgICAgfCA3LjEgICAgfCAxMzAgICAgICAgfCAxMyAgICAgfCA0MTUgICAgICB8CnwgzrExICAgICB8IDczICAgICAgIHwgMi4zICAgIHwgNjAgICAgIHwgMjYgICAgICAgIHwgMTkgICAgIHwgNDggICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya44CK5paw5Z6L5oqX57K+56We55eF6I2v5Y2i576O5ZOM6ZqG5rK755aX57K+56We5YiG6KOC55eH55qE5paw6L+b5bGV44CL77yM5aSq5bmz5rSL6K+B5Yi45pW055CG
收藏
行业数据
2024-10-14
原图定位
查看详情
2022Q1PDB样本医院主要抗精神病药销售金额占比
fCDoja/lk4EgICAgICAgfCDljaDmr5QgIHwKfC0tLS0tLS0tLS0tLXwtLS0tLS18Cnwg5aWl5rCu5bmzICAgICB8IDI2Ljk4JSB8Cnwg5biV5Yip5ZOM6YWuICAgfCAxOC4xMCUgfAp8IOWWueehq+W5syAgICAgfCAxOC4wNyUgfAp8IOmYv+eri+WTjOWUkSAgIHwgMTQuNDElIHwKfCDliKnln7npha4gICAgIHwgNi42NiUgIHwKfCDmsKjno7rlv4XliKkgICB8IDMuNTUlICB8Cnwg6b2Q5ouJ6KW/6YWuICAgfCAzLjEyJSAgfAp8IOWFtuS7liAgICAgICB8IDkuMTElICB8CgrotYTmlpnmnaXmupDvvJrljLvoja/nu4/mtY7miqXvvIxQRELmlbDmja7lupPvvIzopb/pg6jor4HliLjnoJTlj5HkuK3lv4M=
收藏
其它
2024-01-30
原图定位
查看详情
2022Q1PDB样本医院抗精神病药厂家TOP10销售金额
fCBKYW5zc2VuLUNpbGFnIHwg5rGf6IuP6LGq5qOu6I2v5LiaIHwgQXN0cmFaZW5lY2EgfCDpvZDpsoHliLboja8gfCBFbGkgTGlsbHkgfCBEciBSZWRkeSdzIExhYm9yYXRvcmllcyB8IOa1meaxn+Wkp+WutuWItuiNryB8IOaIkOmDveW6t+W8mOiNr+S4miB8IOa5luWNl+a0nuW6reiNr+S4miB8IOaxn+iLj+aBqeWNjuiNr+S4miB8CnwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwgLS0tIHwKfCDplIDllK7ph5Hpop3ljaDmr5QgfCAxNS41NCUgfCAxMy44NyUgfCA5LjExJSB8IDcuMTUlIHwgNi45MSUgfCA2LjE3JSB8IDYuMTQlIHwgNS4yMSUgfCAzLjQ4JSB8IDMuMjIlIHw=
收藏
其它
2024-01-30
原图定位
查看详情
图11、样本医院2022年抗精神病药物销售额占比
fCDoja/niakgICAgIHwg5Y2g5q+UICB8CnwtLS0tLS0tLS0tfC0tLS0tLS18Cnwg5aWl5rCu5bmzICAgfCAyNi41MyV8Cnwg5biV5Yip5ZOM6YWuIHwgMTguMDElfAp8IOWWueehq+W5syAgIHwgMTYuOTAlfAp8IOmYv+eri+WTjOWUkSB8IDExLjM2JXwKfCDliKnln7npha4gICB8IDcuNzAlIHwKfCDlhbbku5YgICAgIHwgMTkuNTAlfAoK6LWE5paZ5p2l5rqQOiBQREIsIOWFtOS4muivgeWIuOe7j+a1juS4jumHkeiejeeglOeptumZouaVtOeQhg==
收藏
其它
2024-01-03
原图定位
查看详情
图15、样本医院2022年抗精神病药物国产和进口
fCDoja/lk4HnsbvlnosgfCDmlbDph4/ljaDmr5QgfAp8LS0tLS0tLS0tfC0tLS0tLS0tLXwKfCDlm73kuqfoja/lk4EgfCA4NyUgICAgIHwKfCDov5vlj6Poja/lk4EgfCAxMyUgICAgIHwKCui1hOaWmeadpea6kO+8mlBEQu+8jOWFtOS4muivgeWIuOe7j+a1juS4jumHkeiejeeglOeptumZouaVtOeQhg==
收藏
其它
2024-01-03
原图定位
查看详情
图12、样本医院2022年三代抗精神病药物销售额
fCDoja/nianku6PmlbAgfCDplIDllK7pop3ljaDmr5QgfAp8LS0tLS0tLS0tfC0tLS0tLS0tLS18Cnwg56ys5LiA5Luj6I2v54mpIHwgMy41MyUgICAgfAp8IOesrOS6jOS7o+iNr+eJqSB8IDg1LjExJSAgIHwKfCDnrKzkuInku6Poja/niakgfCAxMS4zNiUgICB8CgrotYTmlpnmnaXmupA6IFBEQiwg5YW05Lia6K+B5Yi457uP5rWO5LiO6YeR6J6N56CU56m26Zmi5pW055CG
收藏
其它
2024-01-03
原图定位
查看详情
图14、样本医院2022年抗精神病药物国产和进口
收藏
其它
2024-01-03
原图定位
查看详情
图13、样本医院2012-2022年抗精神病药物销售额及数量变化
fCDlubTku70gfCDplIDllK7pop3vvIjnmb7kuIflhYPvvIkgfCDmlbDph4/vvIjnmb7kuIfvvIzlj7PovbTvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18CnwgMjAxMiB8IDEwMDAgICAgICAgICAgICAgfCA0ODAgICAgICAgICAgICAgIHwKfCAyMDEzIHwgMTEwMCAgICAgICAgICAgICB8IDQ2MCAgICAgICAgICAgICAgfAp8IDIwMTQgfCAxMjAwICAgICAgICAgICAgIHwgNDQwICAgICAgICAgICAgICB8CnwgMjAxNSB8IDEzMDAgICAgICAgICAgICAgfCA0MjAgICAgICAgICAgICAgIHwKfCAyMDE2IHwgMTQwMCAgICAgICAgICAgICB8IDQwMCAgICAgICAgICAgICAgfAp8IDIwMTcgfCAxNTAwICAgICAgICAgICAgIHwgMzgwICAgICAgICAgICAgICB8CnwgMjAxOCB8IDE2MDAgICAgICAgICAgICAgfCAzNjAgICAgICAgICAgICAgIHwKfCAyMDE5IHwgMTcwMCAgICAgICAgICAgICB8IDM0MCAgICAgICAgICAgICAgfAp8IDIwMjAgfCAxNjAwICAgICAgICAgICAgIHwgMzIwICAgICAgICAgICAgICB8CnwgMjAyMSB8IDE1MDAgICAgICAgICAgICAgfCAzMDAgICAgICAgICAgICAgIHwKfCAyMDIyIHwgMTQwMCAgICAgICAgICAgICB8IDI4MCAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaUERC77yM5YW05Lia6K+B5Yi457uP5rWO5LiO6YeR6J6N56CU56m26Zmi5pW055CG
收藏
其它
2024-01-03
原图定位
查看详情
图35、全国精神病专科医院门诊患者人数
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
收藏
其它
2024-01-03
原图定位
查看详情
图36、全国精神病专科医院数量变化(家)
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
收藏
其它
2024-01-03
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
匹莫范色林还通过 HARMONY 试验布局痴呆相关精神病适应症,结果显示该类药品具有降低痴呆类型相关精神病复发风险的潜力。HARMONY 试验结果显示,匹莫范色林组的精神病复发率为 13%,而安慰剂组为 28%。在次要终点方面,匹莫范色林组因任何原因提前退出试验的比例为 22%,显著低于安慰剂组的 38%。
行业数据
原图定位
当前图表所属:
绿叶制药-2186.HK-港股公司研究报告:管线创新与商业化渐入佳境CNS创新药龙头价值亟待重估-260417(31页).pdf
抗精神药物的分类
LY03017在研同类竞品梳理
匹莫范色林HARMONY试验结果梳理
匹莫范色林关于帕金森精神病的临床Ⅲ期结果梳理
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》